<DOC>
<DOCNO>EP-0657172</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Endoparasiticide drugs on a basis of open chain tetradepsipeptides
</INVENTION-TITLE>
<CLASSIFICATIONS>C07C23512	A61K3121	A61K3122	A61P3300	C07C23534	C07K1100	A61P3310	C07K1100	C07C23500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07C	A61K	A61K	A61P	C07C	C07K	A61P	C07K	C07C	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07C235	A61K31	A61K31	A61P33	C07C235	C07K11	A61P33	C07K11	C07C235	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention relates to the use of open-chain tetradepsipeptides of the general formula (I) 
<
IMAGE
>
 and their optical isomers and racemates, for controlling endoparasites in human and veterinary medicine.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
BAYER AG
</APPLICANT-NAME>
<APPLICANT-NAME>
BAYER AG
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
HARDER ACHIM DR
</INVENTOR-NAME>
<INVENTOR-NAME>
JESCHKE PETER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
MENCKE NORBERT DR
</INVENTOR-NAME>
<INVENTOR-NAME>
PLANT ANDREW DR
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHERKENBECK JUERGEN DR
</INVENTOR-NAME>
<INVENTOR-NAME>
HARDER, ACHIM, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
JESCHKE, PETER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
MENCKE, NORBERT, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
PLANT, ANDREW, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHERKENBECK, JUERGEN, DR.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of open-chain tetradepsipeptides of the general
formula (I)



in which

A
represents hydrogen, alkyl, aralkyl or an acyl
radical, in particular of the formula -CO-R
9
,
in which
R
9
represents straight-chain or branched
alkyl, alkoxy, aralkyl or aralkoxy having

up to 6 C atoms in the alkyl moiety,
R
1
 and R
4
independently of one another represent
hydrogen, C
1
-C
8
-alkyl, C
3
-C
6
-cycloalkyl or
aralkyl,
R
2
 and R
5
independently of one another represent
hydrogen, straight-chain or branched alkyl

having up to 8 carbon atoms, hydroxyalkyl,
alkanoyloxyalkyl, alkoxyalkyl, aryloxyalkyl,

mercaptoalkyl, alkylthioalkyl, alkylsulphinylalkyl,
alkylsulphonylalkyl, carboxyalkyl, 

alkoxycarbonylalkyl, arylalkoxycarbonylalkyl,
carbamoylalkyl, aminoalkyl, alkylaminoalkyl,

dialkylaminoalkyl, guanidinoalkyl, which can
optionally be substituted by one or two

benzyloxycarbonyl radicals or by one, two,
three or four alkyl radicals, or represent

alkoxycarbonylaminoalkyl,
9-fluorenylmethoxycarbonyl(Fmoc)aminoalkyl,

alkenyl, cycloalkyl, cycloalkylalkyl and
optionally substituted aryl, arylalkyl or

hetarylmethyl, substituents which may be
mentioned being halogen, hydroxyl, alkyl,

alkoxy, nitro or a radical NR
10
R
11
 in which R
10

and R
11
 independently of one another represent
hydrogen or alkyl or R
10
 and R
11
 together with
the adjacent N atom represent a carbocyclic

5-, 6-, 7- or 8-membered ring which can
optionally also be interrupted by O, S and N

and which is optionally substituted by
C
1
-C
4
-alkyl,
R
3
 and R
6
independently of one another represent
hydrogen, straight-chain or branched alkyl

having up to 8 carbon atoms, hydroxyalkyl,
alkanoyloxyalkyl, alkoxyalkyl, aryloxyalkyl,

alkylthioalkyl, alkylsulphinylalkyl, alkylsulphonylalkyl,
carboxyalkyl, alkoxycarbonylalkyl,

arylalkoxycarbonylalkyl,
carbamoylalkyl, aminoalkyl, alkylaminoalkyl,

dialkylaminoalkyl, alkoxycarbonylaminoalkyl,
alkenyl, cycloalkyl, cycloalkylalkyl and

optionally substituted aryl, arylalkyl or
hetarylmethyl, substituents which may be

mentioned being halogen, hydroxyl, alkyl,
alkoxy, nitro or a radical NR
10
R
11
, in which R
10

and R
11
 independently of one another represent
hydrogen or alkyl or R
10
 and R
11
 together with
the adjacent N atom represent a carbocyclic 

5-, 6-, 7- or 8-membered ring which can
optionally also be interrupted by O, S and N

and which is optionally substituted by
C
1
-C
4
-alkyl,
B
represents hydroxyl, alkoxy having up to 4
carbon atoms or the radical NR
7
R
8
 in which
R
7
 and R
8
represent hydrogen, alkyl, aralkyl or
aryl,

and their optical isomers and racemates

for the preparation of endoparasiticidal
compositions.
Endoparasiticidal compositions, characterized in
that they contain at leat one compound of the

formula (I) according to Claim 1.
Process for the preparation of endoparasiticidal
compositions, characterized in that compounds of

the formula (I) according to Claim 1 are mixed with
extenders and/or surfactants.
</CLAIMS>
</TEXT>
</DOC>
